The opposition of Venezuela that is grouped under the figure of the leader Juan Guaidó asked the United Nations Organization (UN) this Friday to demand that the dictator of the Caribbean country, Nicolás Maduro, open “the doors for vaccines to enter” against COVID-19 to this South American nation.
Through letters sent to the secretary general of the organization and to the high commissioner for human rights, António Guterres and Michelle Bachelet, respectively, the opponents urged the UN to issue “a statement against the Venezuelan regime for violating, once again, human rights, access to health and vaccination”.
“We go to this instance because the Venezuelan regime prohibits the entry of the AstraZeneca vaccine into the country”, The opposition continued in the letter.
In mid-March, the Maduro Executive announced that will not allow entry of the AstraZeneca formula considering that the complications will be greater than the benefits derived from the use of this vaccine.
The veto of the Venezuelan regime to the AstraZeneca vaccine was reiterated after the World Health Organization announced that the doses planned for Venezuela through the Covax mechanism were from this laboratory.
“I am not an expert on the matter, but I can say that there are countries that are accepting it“, said to EFE former deputy Williams Dávila, one of the signatories of the letter that the opposition sent to the UN.
“In addition, AstraZeneca is not the only vaccine that is in the Covax pool and we are not in any campaign to disqualify any vaccine, what we demand is that the vaccine be entered,” he added.
In Venezuela, a nation that is going through the worst crisis in its modern history, at least 171,373 people have been infected with COVID-19, of which 1,720 have died.
According to official data, less than 2% of the population has been immunized against COVID-19 in the oil nation.
The Minister for Health, Carlos Alvarado, has said that more than 800,000 doses of the Russian Sputnik V and Chinese Sinopharm formulas have entered the country, and that with these they have vaccinated about 200,000 health workers as well as 50,000 volunteers from a government plan that seeks house-to-house infections.
The regime announced that Venezuela will produce the Cuban vaccine Abdala
The Venezuelan regime confirmed that the Cuban anticovid vaccine Abadala, which is in a trial period, It will be produced in a state laboratory in Caracas and with whose formula he hopes to achieve mass immunization of the population.
The Executive Vice President of Venezuela, Delcy Rodriguezhe said in a statement on public television VTV that Cuban experts visited the plant of the Socialist Company for the Production of Biological Medicines (Espromed Bio), where they verified the conditions for the production of the Abdala vaccine.
Rodríguez did not report when Venezuela expects to begin production of the Cuban vaccine or how many doses per month it expects to develop..
But the Minister of Health, Carlos AlvaradoHe pointed out that the plant, which is managed by the Executive, must undergo some adjustments before starting the manufacture of vaccines.
“These are some actions that we have to take immediately to (…) start the manufacture of vaccines in Venezuela as soon as possible”, He explained.
At the end of last March, the Venezuelan dictator, Nicolas Maduro, said your country will participate in the third phase of tests of the Cuban vaccine candidates Soberana 02 and Abdala, two antidotes with which he hopes to advance mass immunization in the South American country.
But the National Academy of Medicine of Venezuela (ANM) has warned that the Sovereign 02 and Abdala formulas “they are not vaccines“Yet, but”experimental products that have only just begun to be evaluated”.
“Venezuela is suffering from a serious COVID-19 epidemic and, instead of participating in tests of experimental products with unknown characteristics, it should prioritize bringing vaccines of recognized safety and efficacy to the country,” the ANM said in a statement last March.
In that text, academics expressed concern about the effectiveness of these drugs, since “the results of phase 1 and 2” of the tests are not known, and therefore it is not known “if the products are capable of inducing in humans a level and quality of antibodies that can confer protection against the virus” .
(With information from EFE)